SEATTLE—Tomorrow, on Wednesday, April 14, the U.S. Court of Appeals for the Ninth Circuit will hear arguments in Center for Food Safety's (CFS) ongoing lawsuit challenging the U.S.
Corteva Drops Plant-Killing Pesticide Dicamba Amid Legal Battles, Drift Concerns
Corteva Steers Away From Dicamba as Biden Administration to Permit Continued Use of Other Versions, Despite Massive Drift Damage
WILMINGTON, Del.
WASHINGTON—This week, thirteen national advocacy groups concerned about public health, environment, and animal welfare urged key federal agencies to maintain regulatory authority over genetically engineered food animals within the U.S.
Court Rules USDA Authorized to Certify Soil-less Hydroponic Operations as Organic
SAN FRANCISCO—On Friday, the United States District Court for the Northern District issued a ruling in Center for Food Safety's (CFS) lawsuit challenging U.
Call to Restore Ban on Farming Risks in Wildlife Refuges
GM Crops and Neonic Insecticides Incompatible with Refuge Purposes
WASHINGTON—Neither genetically modified (GM) crops nor powerful neonicotinoid insecticides have a place in any Nati.
Opening Brief Filed in Lawsuit Challenging Trump Administration's Expansion of Bee-killing Insecticide Sulfoxaflor
SAN FRANCISCO—Yesterday, Center for Food Safety and the Center for Biological Diversity filed the opening brief in their .
Court of Appeals Backs Environmentalists: Federal Greenlight of Industrial Shellfish Aquaculture Unlawful
Court Agrees Army Corps Violated Several Key Environmental Laws, Permit Still Voided
(Seattle, WA) -- Today, the U.S.
Lawsuit Launched Over Army Corps' Failure to Protect Endangered Wildlife From Nationwide Permit Program
Program Greenlights Environmental Destruction Across Country
PORTLAND, Ore.
Public Oral Argument in Industry Appeal of Federal Court Nullification of Unlawful Shellfish Aquaculture Permit in Washington
(Seattle, WA) -- Tomorrow, on February 2nd, the U.S.
Lawsuit Challenging FDA Approval of Novel Genetically Engineered Color Additive That Makes Impossible Burger "Bleed" Moves Forward
FDA Fails to Demand Needed Tests, Its Approval Not Based on "Convincing Evidence" as Requ.